UBS Group AG - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 26 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q1 2023$9,336
-40.8%
9,336
-48.5%
0.00%
Q4 2022$15,777
+1477.7%
18,134
+3556.0%
0.00%
Q3 2022$1,000
-98.9%
496
-99.5%
0.00%
Q2 2022$91,000
+1416.7%
105,185
+5552.1%
0.00%
Q1 2022$6,000
+50.0%
1,861
+138.3%
0.00%
Q4 2021$4,000
-63.6%
781
+79.5%
0.00%
Q3 2021$11,0004350.00%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q3 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 597,678$771,0000.24%
Kynam Capital Management, LP 739,649$954,0000.20%
RA Capital Management 6,991,003$9,018,0000.19%
Octagon Capital Advisors LP 450,000$581,0000.10%
Ikarian Capital, LLC 219,501$283,0000.06%
UBS OCONNOR LLC 613,931$792,000,0000.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,277,519$1,648,0000.00%
ROCKY MOUNTAIN ADVISERS, LLC 1,200$2,0000.00%
CSS LLC/IL 38,721$50,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 26,867$35,0000.00%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders